Mrv0541 05031423452D 20 19 0 0 1 0 999 V2000 4.9204 -1.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7770 -0.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9204 -0.7145 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0625 -0.7145 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.4914 -0.7145 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 5.6349 -0.3020 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3480 -0.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3493 -0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0625 -1.5395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.6349 0.5230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.4914 -1.5395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.6336 -0.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3480 0.5230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 7.0638 -0.3020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.3493 -1.5395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.2059 -0.3020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7329 -0.8577 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0625 0.1105 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.7770 -1.1270 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 5.9170 -1.0772 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 1 0 0 0 4 2 1 0 0 0 0 5 2 1 0 0 0 0 6 3 1 0 0 0 0 7 4 1 0 0 0 0 8 6 1 0 0 0 0 4 9 1 1 0 0 0 6 10 1 1 0 0 0 5 11 1 1 0 0 0 12 7 2 0 0 0 0 13 7 1 0 0 0 0 14 8 2 0 0 0 0 15 8 1 0 0 0 0 16 3 1 0 0 0 0 16 5 1 0 0 0 0 3 17 1 6 0 0 0 4 18 1 1 0 0 0 5 19 1 6 0 0 0 6 20 1 1 0 0 0 M END > DB01817 > drugbank > [H][C@](N)(C[C@]([H])(O)O[C@]([H])(C)[C@]([H])(N)C(O)=O)C(O)=O > InChI=1S/C8H16N2O6/c1-3(6(10)8(14)15)16-5(11)2-4(9)7(12)13/h3-6,11H,2,9-10H2,1H3,(H,12,13)(H,14,15)/t3-,4+,5-,6+/m1/s1 > VCAYFLVMRCFGDV-MOJAZDJTSA-N > C8H16N2O6 > 236.2224 > 236.100836254 > 8 > 32 > -0.04123123442423215 > 21.936719569582834 > 1 > 5 > 0 > 0 > (2S,3R)-2-amino-3-[(1R,3S)-3-amino-3-carboxy-1-hydroxypropoxy]butanoic acid > -4.21 > -6.290377826057272 > -0.92 > 0 > 0 > 0 > 0 > 2.3245755719572303 > 1.6178840561427623 > 9.199619390529067 > 156.1 > 50.4724 > 7 > 1 > 2.81e+01 g/l > tetrahydrofolic acid > 0 > DB01817 > EXPT00445 > experimental > Threonine-Aspartic Ester $$$$